Vitamin E treatment of nonalcoholic steatohepatitis in children: A pilot study

Journal of Pediatrics

Volumn 136, Issue 6, 2000, Pages 734-738

  Lavine, Joel E ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UCSD MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ALPHA TOCOPHEROL; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CHOLESTEROL;

ADOLESCENT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY MASS; CLINICAL ARTICLE; CLINICAL TRIAL; ECHOGRAPHY; FATTY LIVER; FEMALE; HUMAN; MALE; OBESITY; PILOT STUDY; PRIORITY JOURNAL; SCHOOL CHILD; VITAMIN BLOOD LEVEL; WEIGHT REDUCTION;

EID: 0034126755     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(00)05040-X     Document Type: Article

References (16)

1. 1. Franzese A, Vajro P, Argenziano A, Puzziello A, Iannucci M, Saviano M, et al. Liver involvement in obese children: ultrasonography and liver enzyme levels at diagnosis and during follow-up in an Italian population. Dig Dis Sci 1997;42:1428-32.
2. 2. Gortmaker S, Dietz W, Sobol A, Wehler C. Increasing pediatric obesity in the United States. Am J Dis Child 1987;141:535-40.
3. 3. Baldridge A, Perez-Atayde A, Graeme-Cook F, Higgins L, Lavine J. Idiopathic steatohepatitis in childhood: a multicenter retrospective study. J Pediatr 1995;127:700-4.
4. 4. Ludwig J, Viggiano T, McGill D, Ott B. Mayo Clinic experience with a hitherto unnamed disease. Mayo Clin Proc 1980;55:434-8.
5. 5. Rashid M, Roberts E. Nonalcoholic steatohepatitis in children. J Pediatr Gastroenterol Nutr 2000;30:48-53.
6. 6. Vajro P, Fontanella A, Perna C, Orso G, Tedesco M, DeVincenzo A. Persistent hyperaminotransferasemia resolving after weight reduction in obese children. J Pediatr 1994;125:239-41.
7. 7. Kinugasa A, Tsunamoto K, Furukawa N, Sawada T, Kusunoki T, Shimada N. Fatty liver and its fibrous changes found in simple obesity of children. J Pediatr Gastroenterol Nutr 1984; 3:408-14.
8. 8. Laurin J, Lindor K, Crippin J, Gossard A, Gores G, Ludwig J, et al. Ursodeoxycholic acid or clofibrate in the treatment of nonalcohol-induced steatohepatitis: a pilot study. Hepatology 1996;23:1464-7.
9. 9. Day C, James O. Steatohepatitis: a tale of two "hits"? Gastroenterology 1998;114:842-5.
10. 10. Teli M, James O, Burt A, Bennett M, Day C. The natural history of nonalcoholic fatty liver: a follow-up study. Hepatology 1995;22:1714-9.
11. 11. Berson A, De Beco V, Letteron P, Robin M, Moreau C, El Kahwaji J, et al. Steatohepatitis-inducing drugs cause mitochondrial dysfunction and lipid peroxidation in rat hepatocytes. Gastroenterology 1998;114:764-74.
12. 12. Pietrangelo A. Metals, oxidative stress and hepatic fibrogenesis. Semin Liver Dis 1996;16:13-30.
13. 13. Day C, James O. Hepatic steatosis: Innocent bystander or guilty party? Hepatology 1998;27:1463-6.
14. 14. Tazawa Y, Noguchi H, Nishinomiya F, Takada G. Serum alanine aminotransferase activity in obese children. Acta Paediatr 1997;86:238-41.
15. 15. Noguchi H, Tazawa Y, Nishinomiya F, Takada G. The relationship between serum transaminase activities and fatty liver in children with simple obesity. Acta Paediatrica Japonica 1995;37:621-5.
16. 16. Strauss R. Comparison of serum concentrations of α-tocopherol and β-carotene in a cross-sectional sample of obese and non-obese children (NHANES III). J Pediatr 1999;134:160-5.